ACCP is proud to continue its work in collaborating with partners across health care disciplines on the “Innovating Decisions and Empowering Action in Diabetes Management” initiative.

ACCP is extending its commitment to support an interprofessional initiative spearheaded by the American Association of Clinical Endocrinologists that provides innovative programming intended to change how continuous glucose monitoring (CGM) data are interpreted and used by health care practitioners. The Innovating Decisions and Empowering Action in Diabetes Management, or IDEA, project provides a guide for the development and distribution of teaching and learning resources to make use of the best practice standards discussed in the CGM Glucose Pattern Summary and Blood Glucose Pattern Summary reports on providing care for patients with diabetes. The initiative was born out of the idea that as glucose practices and information change, providers will face an evolution in their support of glucose management.

Content for the IDEA project was designed to address educational gaps in the diabetes community, including the underuse of glucose monitoring as part of diabetes management, the frequency with which hypoglycemia goes undetected, and the inability of A1C to capture glycemic excursions. Participation in the programming will hopefully generate new ideas regarding increased shared decision-making and personalized patient care. Phase 2 of the education content is set to be developed and available by the end of 2020. As part of ACCP’s participation in phase 1, pharmacists are still eligible for 3 hours of free continuing education credit by completing the currently available content. The content is hosted on the American Association of Diabetes Educators website and can be accessed here.